Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether proactive use of 0.1% tacrolimus ointment once or twice weekly can keep adult facial SD in remission and reduce the incidence of exacerbation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pusan National University Hospital
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• at least 18 years of age with a diagnosis of facial seborrhoeic dermatitis

Exclusion Criteria:

• taking other systemic or topical treatments for facial seborrhoeic dermatitis within the previous 4 weeks

• a known allergy to the components of tacrolimus ointment

• malignant neoplasm; immunologic abnormality

• active infection

• other definitive cutaneous findings such as erythroderma, acne, and psoriasis